Open AccessAcquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer
Author(s) -
Ken Suzawa,
Michael Offin,
Adam J. Schoenfeld,
Andrew J. Plodkowski,
Igor Odintsov,
Daniel Lu,
William W. Lockwood,
Maria E. Arcila,
Charles M. Rudin,
Alexander Drilon,
Helena A. Yu,
Gregory J. Riely,
Romel Somwar,
Marc Ladanyi
Publication year - 2019
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.19.00011
Subject(s) - epidermal growth factor receptor , lung cancer , cancer research , tyrosine kinase , receptor tyrosine kinase , growth factor receptor inhibitor , exon , tyrosine kinase inhibitor , acquired resistance , biology , receptor , kinase , medicine , cancer , microbiology and biotechnology , genetics , gene